research-and-development
(3)
Boston Micro Fabrication (BMF)
Boston Micro Fabrication (BMF) builds 3D printers that work at a scale most machines can't reach - resolutions down to 2 microns with tolerances of about plus or minus 10 microns. Its microArch printers use a proprietary process called Projection Micro Stereolithography (PuSL) to make tiny, complex parts for medical devices, microfluidics, optics, connectors and semiconductor packaging. Founded in 2016 and headquartered in Maynard, Massachusetts, BMF has placed machines with more than 2,000 customers across roughly 35 countries.
Huawei
Huawei is a Shenzhen-based technology company and the world's largest maker of telecommunications equipment. Founded in 1987 by Ren Zhengfei, it now spans carrier networks, enterprise ICT, cloud computing, digital power, and a consumer business that builds smartphones, wearables, and the homegrown HarmonyOS operating system. Despite years of U.S. sanctions, the company posted roughly 880.9 billion yuan in 2025 revenue and pours over a fifth of that back into R&D.
BreezeBio
BreezeBio (formerly GenEdit) is a Brisbane, California-based biotechnology company that develops precision genetic medicines using its proprietary NanoGalaxy platform - a library of polymer nanoparticles capable of delivering genetic payloads like mRNA, siRNA, and CRISPR components to specific tissues without triggering immune responses. Unlike viral vectors that can only be dosed once and often provoke dangerous immune reactions, BreezeBio's non-viral approach allows repeat dosing, broad payload flexibility, and tissue selectivity across immune cells, heart, lung, and CNS. Founded in 2016 out of UC Berkeley by CEO Dr. Kunwoo Lee and CTO Dr. Hyo Min Park, the company rebranded from GenEdit in early 2026 following its $60M Series B, signaling a shift from delivery-platform licensor to full therapeutic developer with a lead program (BRZ-101) targeting Type 1 Diabetes.